Ropivacaine Hydrochloride Injection, Solution
Product Images NDC 55150-196

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 55150-196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel-0.2% (2 mg/ml) (20 mL Container Label)

Label for Ropivacaine Hydrochloride Injection, USP 0.2% (2 mg/mL) in a 20 mL single-dose vial. The label states it is for infiltration, nerve block, and epidural administration only, not for intravenous use. Distributed by Auro Medics Pharma LLC and made in India.*

FDA Label Image

Package Label-principal Display Panel-0.75% (7.5 mg/ml) (20 mL Container-Carton (25 Vials))

Packaging label for Ropivacaine Hydrochloride Injection, USP 0.75% (7.5 mg/mL), 150 mg/20 mL. Contains 25 single dose vials of 20 mL each. Sterile, nonpyrogenic solution for nerve block and epidural administration only, not for intravenous use. Distributed by AuroMedics Pharma LLC. Includes dosage and storage information and manufacturer details.*

FDA Label Image

Package Label-principal Display Panel-1% (10 mg/ml) (10 mL Container Label)

Ropivacaine Hydrochloride Injection, USP 1%, 100 mg/10 mL (10 mg/mL) single dose vial label. Indicates epidural administration only, not for intravenous use. Contains 10 mg/mL ropivacaine hydrochloride USP with sodium chloride and pH adjusters. Manufactured in India for AuroMedics Pharma LLC, E. Windsor, NJ 08520. Sterile, nonpyrogenic, with storage instructions and barcode visible.*

FDA Label Image

Package Label-principal Display Panel-1% (10 mg/ml) (10 mL Container-Carton (25 Vials))

Label for Ropivacaine Hydrochloride Injection USP 1% (100 mg/10 mL, 10 mg/mL) by Auromedics. The label states that it is sterile, nonpyrogenic, and intended for epidural administration only, not for intravenous use. Packaging is for 25 single-dose 10 mL vials. Distributed by AuroMedics Pharma LLC, made in India, with storage instructions and ingredients listed.*

FDA Label Image

Package Label-principal Display Panel-1% (10 mg/ml) (20 mL Container Label)

Label for Ropivacaine Hydrochloride Injection, USP 1% (10 mg/mL) in a 20 mL single dose vial. The label indicates a total of 200 mg per 20 mL vial, for epidural administration only, not for intravenous use. Distributed by AuroMedics Pharma LLC, made in India, with storage instructions and ingredient details included.*

FDA Label Image

Package Label-principal Display Panel-1% (10 mg/ml) (20 mL Container-Carton (25 Vials))

Packaging label for Ropivacaine Hydrochloride Injection, USP 1% (10 mg/mL) with a total of 200 mg in 20 mL. This sterile, nonpyrogenic injection is intended for epidural administration only, not for intravenous use. The box contains 25 single-dose vials of 20 mL each. Distributor is AuroMedics Pharma LLC, with manufacturing in India.*

FDA Label Image

Package Label-principal Display Panel-0.2% (2 mg/ml) (20 mL Container-Carton (25 Vials))

Packaging label for Ropivacaine Hydrochloride 0.2% Injection, USP, with a concentration of 40 mg/20 mL (2 mg/mL). The label indicates sterile, nonpyrogenic single-dose vials, 25 x 20 mL. Use is specified for infiltration, nerve block, and epidural administration only, not for intravenous use. Distributed by AuroMedics Pharma LLC, with manufacturing in India.*

FDA Label Image

Package Label-principal Display Panel-0.2% (2 mg/ml) (100 mL Container Label)

Ropivacaine Hydrochloride Injection USP 0.2% (2 mg/mL) in a 100 mL single dose infusion bottle. The label indicates a total of 200 mg per 100 mL. It is for infiltration, nerve block, and epidural administration only, not for intravenous use. The product is sterile, nonpyrogenic and distributed by AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel-0.2% (2 mg/ml) (100 mL Container-Carton (1 Vial))

Packaging label for Ropivacaine Hydrochloride Injection, USP 0.2% (2 mg/mL) in a 100 mL single dose infusion bottle. The label indicates the product contains 200 mg per 100 mL, is for infiltration, nerve block, and epidural administration only, not for intravenous use. It is supplied by Auromedics Pharma LLC and made in India.*

FDA Label Image

Package Label-principal Display Panel-0.5% (5 mg/ml) (20 mL Container Label)

Ropivacaine Hydrochloride Injection USP 0.5% (5 mg/mL), 100 mg/20 mL in a single dose vial. The label indicates it is for infiltration, nerve block, and epidural administration only, not for intravenous use. The product is distributed by AuroMedics Pharma LLC and made in India. The label includes storage instructions and mentions the solution is sterile and nonpyrogenic.*

FDA Label Image

Package Label-principal Display Panel-0.5% (5 mg/ml) (20 mL Container-Carton (25 Vials))

Packaging label for Ropivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) solution. The label indicates a 100 mg/20 mL dosage strength in sterile, nonpyrogenic single-dose vials, with a package size of 25 vials of 20 mL each. The product is for infiltration, nerve block, and epidural administration only, not for intravenous administration. The label includes manufacturer information for Auromedics Pharma LLC and storage instructions.*

FDA Label Image

Package Label-principal Display Panel-0.5% (5 mg/ml) (30 mL Container Label)

Label for Ropivacaine Hydrochloride Injection, USP 0.5% with strength 5 mg/mL in a 30 mL single dose vial. The label shows the total amount as 150 mg per 30 mL and indicates use for infiltration, nerve block, and epidural administration with a warning against intravenous administration. Distributed by AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel-0.5% (5 mg/ml) (30 mL Container-Carton (25 Vials))

Packaging label for Ropivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) by Auromedics Pharma LLC. This prescription drug is supplied as 150 mg/30 mL in 25 single-dose vials. The label states it is sterile, nonpyrogenic, and intended for infiltration, nerve block, and epidural administration only, not for intravenous use. The package includes dosage and storage instructions and a barcode.*

FDA Label Image

Package Label-principal Display Panel-0.75% (7.5 mg/ml) (20 mL Container Label)

Ropivacaine Hydrochloride 0.75% Injection, USP, 150 mg/20 mL (7.5 mg/mL) in a 20 mL single-dose vial. Label indicates the product is sterile, nonpyrogenic, for nerve block and epidural administration only, not for intravenous use. Distributed by AuroMedics Pharma LLC, made in India, with storage instructions and barcode visible.*

FDA Label Image

Ropivacaine Hydrochloride Chemical Structure (Ropivacaine Str1)

Chemical structure of Ropivacaine Hydrochloride, showing its molecular formula C17H26N2O · HCl · H2O and molecular weight of 328.89. The diagram includes the aromatic ring, amide linkage, piperidine ring, and associated hydrochloride and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.